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a b s t r a c t
Many carbonyl species from either lipid peroxidation or glycoxidation are extremely reactive and can
disrupt the function of proteins and enzymes. 4-hydroxynonenal and methylglyoxal are the most
abundant and toxic lipid-derived reactive carbonyl species. The presence of these toxics leads to
carbonyl stress and cause a signiﬁcant amount of macromolecular damages in several diseases. Much
evidence indicates trapping of reactive carbonyl intermediates may be a useful strategy for inhibiting
or decreasing carbonyl stress-associated pathologies. There is no rapid and convenient analytical
method available for the assessment of direct carbonyl scavenging capacity, and a very limited
number of carbonyl scavengers have been identiﬁed to date, their therapeutic potential being
highlighted only recently. In this context, we have developed a new and rapid sensitive ﬂuorimetric
method for the assessment of reactive carbonyl scavengers without involvement glycoxidation
systems. Efﬁcacy of various thiol- and non-thiol-carbonyl scavenger pharmacophores was tested both
using this screening assay adapted to 96-well microplates and in cultured cells. The scavenging
effects on the formation of Advanced Glycation End-product of Bovine Serum Albumin formed with
methylglyoxal, 4-hydroxynonenal and glucose-glycated as molecular models were also examined. Low
molecular mass thiols with an α-amino-β-mercaptoethane structure showed the highest degree of
inhibitory activity toward both α,β-unsaturated aldehydes and dicarbonyls. Cysteine and cysteamine have
the best scavenging ability toward methylglyoxal. WR-1065 which is currently approved for clinical use
as a protective agent against radiation and renal toxicity was identiﬁed as the best inhibitor of 4-
hydroxynonenal.
& 2014 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
Reactive carbonyl species (RCS), especially α-dicarbonyl com-
pounds, are key mediators of damage caused by oxidative stress
and glycation. RCS, as reactive intermediates of cellular carbonyl
stress, originate from a multitude of mechanistically related path-
ways such as glycation [1], sugar autoxidation [2], lipid peroxida-
tion [3], and UV-photodamage [4]. Cellular carbonyl stress results
in protein damage referred to as glycation by spontaneous chemi-
cal reaction between RCS, such as reducing sugars and more
reactive dicarbonyl compounds, with proteins to cause oxidation
of their polypeptide backbone, peptide bond cleavage, protein–
protein cross-linking, and a range of amino acid side-chain
modiﬁcations [5]. Both free and protein-bound carbonyls can also
directly affect cellular function through multiple pathways, includ-
ing enzyme inhibition [6].
Compared to free radicals, lipid-derived RCS are stable and can
diffuse within or even escape from the cell and attack targets far
from the site of formation. Therefore, these soluble reactive inter-
mediates are not only cytotoxic but also behave as mediators and
propagators of oxidative stress and tissue damage, acting as second
cytotoxic messengers. Interestingly, RCS can exert their detrimental
cellular effects by increasing reactive oxygen species (ROS) produc-
tion [7], thereby forming a vicious cycle of ROS and RCS production.
The α,β-unsaturated aldehydes 4-hydroxynonenal (HNE), acrolein,
and dicarbonyls methylglyoxal (MG) are the most abundant and
toxic lipid-derived RCS. HNE is, generated through the β-cleavage of
hydroperoxides from ω-6 polyunsaturated fatty acids. MG is origi-
nated from non-enzymatic dephosphorylation of triosedihydroxya-
cetone phosphate and glyceraldehyde-3-phosphate as well as the
lipid peroxidation, the glucose auto-oxidation and degradation
of glycated proteins. These reactive and electrophilic compounds
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act as key factors in the development and progression of a variety of
chronic diseases such as cardiovascular (e.g., atherosclerosis, long-
term complications of diabetes) and neurodegenerative diseases,
cerebral ischemia, rheumatoid arthritis, and post-ischemic reoxy-
genation injury [8–10].
Among the different approaches that can be considered to
prevent or restrain the RCS-induced damage, that based on a
direct trapping of reactive aldehydes seems to be the most
promising, and represents a good therapeutic target. Even if this
strategy will not completely abolish or contain the oxidative stress,
it can be useful to reduce the toxicological consequences of RCS
attack and slow down the progression of pathological events.
Currently, there is no convenient analytical method available
for the assessment of direct carbonyl scavenging capacity, and a
very limited number of inhibitors of cellular carbonyl stress have
been identiﬁed to date. Carbonyl scavenger effect of various
compounds was measured by evaluating their cytoprotective
effect [11–14] or their ability to decrease the protein carbonyl
content on cultured cells [13–16]. Some inhibitors of glycation
interfere with the reaction by trapping intermediate α-dicarbonyls
[17–19], whereas other inhibitory substances act merely as anti-
oxidants and transition metal chelators [20]. In vitro AGE ﬂuorescence
or immunological quantiﬁcation of speciﬁc AGEs is complicated by
the nature of employed glycoxidative reaction systems for screening
α-dicarbonyl scavenger.
Carbonyl compounds are sparingly absorbent and do not
exhibit native ﬂuorescence. A highly ﬂuorescent, light-stable
chromophore with a suitable anchor group is needed for the
labelling of carbonyl compounds in order to get a stable and
strong ﬂuorescence signal, especially if an intense light source is
applied. If the labelling reagent itself is ﬂuorescent, a strong
ﬂuorescent background signal will be obtained from the non-
converted reagent. Therefore, better results are expected for non-
ﬂuorescent labelling reagents that form highly ﬂuorescent carbonyl
adducts.
In the present study, we present a convenient, rapid and
sensitive ﬂuorimetric method for high-throughput assessment of
both reactive monocarbonyls and dicarbonyl scavengers without
involvement glycoxidation systems. The method reported here is
based on the reaction of carbonyl compounds with 7-hydrazino-4-
nitrobenzo-2,1,3-oxadiazole (NBD-H) to form highly ﬂuorescent
derivatives via hydrazone formation [21].
To conﬁrm the reliability of this method, various RCS-sequestering
compounds and pharmacophores known as therapeutic agents to
protect cells against carbonyl stress were also tested on cultured
cells and with two other screening assays speciﬁcally designed for
aliphatic monocarbonyl and dicarbonyls scavengers respectively.
A strong correlation between RCS trapping ability measured with
the proposed NBD-H assay and the other assays was revealed.
Efﬁcacy of other thiol- and non-thiol-carbonyl scavenger pharma-
cophores from approved drug was then tested using our NBD-H
assays. Their inhibitory activity was also evaluated on the forma-
tion of AGE using MG, HNE and glucose-glycated BSA as molecular
models.
Materials and methods
Reagents and materials
4‐hydroxynonenal was purchased from Cayman (Ann Arbor,
MI, USA). Luciferin-luciferase reagent (Biofax A) was purchased
from Yelen (Ensues la redone, France). Other reagents are from
Sigma-Aldrich (St. Louis, MO, USA) with analytical grade. HNE was
pre-diluted in DMSO prior to usage. Other RCS studied are freely
soluble in water (100–600 g/l at 20 1C) and were tested in aqueous
soluble range concentrations. Screening assays were performed
with a microplate spectroﬂuorimeter TECAN Inﬁnite 200 (TECAN,
Männedorf, Switzerland)
Cell culture and cytotoxicity evaluation
X63-Ag8.653 HGPRT deﬁcient mouse Balb/c myeloma cells [22]
were cultured in RPMI-1640 or 90% Dulbecco's MEM gluta-
max plus supplemented with 10% heat-inactivated fetal bovine
serum (FBS), sodium bicarbonate, 2 mM L-glutamine, 100 U/ml
penicillin and 100 μg/ml streptomycin. The cells were maintained
at 0.1–1.106 cells/ml; optimal split ratio of 1/10–1/20 every 48 h;
15103 cells per well were incubated 24 h without or with
various concentrations of RCS at 37 1C with 10% CO2 and without
FBS in 96-well plates.
Caco-2 cells cell line (generous gift of Dr. Massey-Harroche,
IBDML, Marseille, France) were routinely grown in Dulbeco's
modiﬁed essential medium (DMEM) or supplemented with 10%
foetal calf serum (FCS), 1% L-glutamine and 1% antibiotics (all from
Invitrogen) and maintained in a 5% CO2 incubator at 37 1C. For
studying toxics or molecules effects, Caco-2 cells were seeded at a
density of 20103 cells per well in 96-well plates and let to
differentiate with medium changed every 2 days. After 6–8 days of
differentiation, Caco-2 monolayers were incubated 24 h without or
with RCS diluted to the appropriate density in DMEM (without FCS
or antibiotics).
Cytotoxicity was determined by measurement of intracellular
ATP content using the luciferin–luciferase reaction [23]. Brieﬂy, cells
were lysed by adding Triton X-100 at a ﬁnal concentration of 1%.
100 mL of cell lysates were collected and transferred into 96-well
plates after 5-min incubation,. One hundred microliters of luciferin–
luciferase reagent (Yelen, France) were then immediately added
before luminescent signal was quantiﬁed in a microplate lumin-
ometer TECAN Inﬁnite 200 (TECAN, Männedorf, Switzerland).
We evaluated the protective effects of the carbonyl scavengers
by comparing the intracellular ATP content of untreated cells with
cells exposed to carbonyl stress7test compounds.
Global carbonyls scavenger evaluation (NBD-H assay)
This assay is base on the reaction of NBD-H with both mono
and dicarbonyls compounds via hydrazone formation to form
highly ﬂuorescent products. NBD-H solution was prepared at
200 mM in 100 mM phosphate buffer, pH 7.4 with 1 M HCL. RCS
(MG and HNE) and carbonyl scavenger solutions were prepared in
100 mM phosphate buffer, pH 7.4. 100 ml of each carbonyl solution
(100 mM) was incubated 30 min at 37 1C with 100 ml of phosphate
buffer or 100 ml of carbonyl scavenger solutions at various con-
centrations in 96 wells microplate. 100 ml of NBD-H solution was
then added in each well and ﬂuorescence was measured at
560 nm, exciting at 500 nm after 5 min. The % inhibition of NBD-
H adduct formation was calculated for each compound from the
ﬂuorescence response versus concentration. Each treatment was
compared with control without scavenger, and statistical signiﬁ-
cance between two groups was evaluated using Student's t test.
One-way analysis of variance (ANOVA) was used for the data
presented in Table 2 with post-hoc multiple comparison by a
Bonferroni test using the Graph Prism program. The criterion for
signiﬁcance was set at po0.05.
Dicarbonyl scavenger evaluation (TRI assay)
This assay is based on the reaction of α-dicarbonyl compounds
with 6-hydroxy-2,4,5 triaminopyrimidine (TRI) to form the corre-
sponding ﬂuorescent pteridinic derivatives [24]. MG used as
α-dicarbonyl compound reacts with TRI to form 6,7-dimethylpterin.
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MG, carbonyl scavengers and TRI solutions were prepared in
300 mM phosphate buffer (pH 7.4). 100 ml of MG solution (6 mM)
was incubated 1 h at 37 1C with 100 ml of phosphate buffer or
100 ml of carbonyl scavenger solutions at various concentrations in
96 wells microplate. 100 ml of TRI solution (60 mM) was then added
in each well and ﬂuorescence was measured at 445 nm, exciting at
350 nm after 1 h. The % inhibition of TRI-MG formation is
calculated for each compound from the ﬂuorescence response
versus concentration.
Monocarbonyls scavenger evaluation (CHD assay)
Aldehydes can be condensed with 1,3 cyclohexanedione (CHD) and
ammonium ion to form highly ﬂuorescent and stable water-soluble
adduct. CHD can easily react with aliphatic mono-unsaturated alde-
hydes such as HNE but poorly with α-dialdehydes such as glyoxal and
methylglyoxal. CHD is also a good ﬂuorescence labelling reagent for
determination of mono-carbonyl compounds [25].
RCS (HNE) and carbonyl scavenger solutions were prepared in
100 mM phosphate buffer, pH 7.4. The derivatization reagent
solution was prepared with 0.4 g of ammonium acetate and
13 mg of CHD diluted in 10 ml of 100 mM phosphate buffer, pH
7.4. 100 ml of each carbonyl solution (100 mM) was incubated
60 mn at 37 1C with 100 ml of phosphate buffer or 100 ml of
carbonyl scavenger solutions at various concentrations in 96 wells
microplate. 100 ml of CHD solution was then added in each well
and incubated 60 min at 37 1C. The ﬂuorescence was measured at
460 nm, exciting at 395 nm. The % inhibition of CHD adduct
formation was calculated for each compound from the ﬂuores-
cence response versus concentration.
BSA assay
BSA (50 mg/ml) was incubated 24 h at 37 1C with MG (5 mM)
or HNE (5 mM) or glucose (20 mM) in 300 mM phosphate buffer
(pH 7.4) in the presence or absence of various compounds.
Fluorescence of the advanced glycated end-products [26] was
monitored using a microplate spectroﬂuorimeter. Speciﬁc ﬂuores-
cence was employed for each carbonyl: λex¼330/λem¼392, λex¼
345/λem¼396, λex¼330/λem¼394 for MG, HNE and glucose
respectively. BSA alone was used as a control. The % inhibition of
AGE formation in the test sample versus control was calculated for
each inhibitor compounds using Graphpad software. IC50 values
are expressed in equivalent of aminoguanidine. One-way analysis
of variance (ANOVA) was used for the data presented in Fig. 6.
High-performance liquid chromatography analysis
Chromatographic analysis was performed using a Waters
AllianceTM System equipped with a Waters 2690 XE separation
module and a Waters 474 Scanning ﬂuorescence detector con-
trolled by the Waters MilleniumTM Chromatography manager
software.
Separation of MG-TRI adduct was achieved at room tempera-
ture on a Alltima HP C18 column (250 mm4.6 mm; 5 mm) with a
isocratic ﬂow rate of 0.8 mL min1. Solvent A is 20 mM phosphate
buffer (pH 6.9); solvent B is methanol. The elution programme
with linear gradients was the following: 0 min, 10% B; 15 min, 15%
B; 16 min 80% B; 20 min 80% B; 21 min 10% B; 27 min reinjection
20 ml. Derivatives were measured at excitation and emission
wavelengths of 365 nm and 447 nm, respectively. Quantiﬁcation
is based on peak area.
Results
Cytotoxicity
The cellular toxicity of carbonyl compounds such as G, MG and
HNE has been well established in various neuronal cells [27,28],
macrophage-derived cell lines [29], and intestinal cells (Caco-2
and HT-29) [30]. Then, we were interested in assessing carbonyl
toxicity both on Caco-2 and high sensitive myeloma cell lines,
which are extensively used in cell-based assays.
Six mono and dicarbonyl compounds were ﬁrst subjected to
the screening test of cytotoxic activity. Increasing concentrations
of all RCS excepted hexanal resulted in a concentration-dependent
growth inhibition of the two type of cell culture. The overall
cytotoxic potential of the RCS evaluated is evident from data
presented in Table 1, which represent the concentration (IC50
value) of the respective carbonyl compounds that inhibited cell
viability by 50% as compared to controls. Caco-2 cells are slightly
less sensitive toward all carbonyls tested than myeloma. We
observed that both cell lines present a retardation of cell growth
when exposed to micromolar concentration for all compounds
except hexanal which has no cytotoxic effect. Acrolein and HNE
are the most cytotoxic on myeloma cell cultures (IC50o10 mM),
whereas the toxicity of formaldehyde (IC50E100 mM) and MG
(IC50E350 mM) are markedly less. Our data are consistent with
previous reports describing the toxicities of various aldehydes [31].
Carbonyls scavenging on cell culture
As the cellular toxicity of MG and HNE has been established in
our cell experiments and well described in the literature in various
cells, we were interested in assessing protection of these carbonyls
toxicity by scavengers using mouse myeloma cell culture model.
Cells were exposed to MG or HNE at higher concentration than
their cytotoxic IC50 values (see Table 1) in the absence or presence
of carbonyl scavengers. Hence, cell experiments were carried out
with 1 mM of MG and 100 mM of HNE in order to increase cellular
toxicity during 24 h exposure. The effectiveness of test compounds
was assessed on cell growth. Increasing concentrations of each
carbonyl scavenger resulted in increased protection in cell types.
No signiﬁcant cellular toxicity is observed with the tested com-
pounds alone during a 24 h exposure to mouse myeloma cells.
Results reported in Table 2, express the concentration (IC50 value)
of the scavengers corresponding to 50% of toxicity induced by
carbonyls.
Cysteine and penicillamine similarly protect myeloma against
growth inhibition by MG and are the most effective. Protective
effect of aminoguanidine is slightly less than cysteine or penicilla-
mine but two fold higher than glutathione and more than six fold
Table 1
Cytotoxicity values of RCS incubated 24 h at 37 1C in mouse myeloma B X63Ag5815
and caco2 cells. Cytotoxicity is determined by measurement of intracellular ATP
content using the luciferin–luciferase reaction. Percent viability relative to control
is calculated for the various RCS in each cell line and used to calculated IC50 values
for growth inhibition.
Compounds Cytotoxic concentration IC50 (mM)
Lymphome B Caco2
Acrolein 3–6 nd
Formaldehyde 62.5–125 312–625
Methylglyoxal 250–500 625–1250
4-HNE 5–10 10–15
glyoxal 625–1250 nd
hexanal 410 000 nd
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higher than NAC. Metformin is not protective. Compared to MG
toxicity, protective effect of test compounds against HNE toxicity is
much weaker (10 fold less in average). Penicillamine and NAC are
the most effective against HNE toxicity. This protective effect is
likely due to a direct chemical scavenging of the toxic MG and
HNE, because pre-incubation of cells with scavengers for 24 h
followed by exposure to the RCS in the absence of either com-
pound do not show any protective effect (data not shown).
Screening assays for carbonyl scavengers
We performed screening assays for MG and HNE scavengers
using TRI, CHD and NBD-H reagents. These reagents are not
naturally ﬂuorescent but their reaction with aldehydes and ketone
give highly ﬂuorescent derivatives (Fig. 1). CHD do not react with
dicarbonyls, but can easily react with aliphatic monocarbonyls (via
Hantzsch reaction) to form highly stable and water-soluble adduct.
TRI do not react with monocarbonyls but form ﬂuorescent 6,7-
dimethylpterin derivatives with dicarbonyls.
In our conditions, the ﬂuorescence response reaches a max-
imum value after 1 h and 45 min for CHD and TRI respectively. The
derivatives products are stable during few hours.
NBD-H is a more convenient probe than TRI and CHD as it react
strongly with both mono and dicarbonyl compounds to convert
them into ﬂuorescent hydrazones. The ﬂuorescence is easily seen
after few seconds and the reaction is complete within 6–8 min, but
contrary to TRI or CHD, derivatives products are not so stable. For
each assay, RCS and carbonyls were incubated together 1 h before
the probe addition. Results are expressed in molar ratio scavenger/
carbonyl corresponding to 50% of reagent derivatives inhibition.
Scavenging agents of α,β-dicarbonyls are useful to prevent the
formation of AGEs from α,β-dicarbonyl precursors and of α,β-
dicarbonyl moieties of glycated proteins [32]. For this purpose,
we developed as a ﬁrst step a screening assay for MG scavengers
using TRI reagent. Results in Table 2 show the molar ratio
scavenger/MG corresponding to 50% of inhibition of TRI-MG
formation. The tested compounds do not react to the same way
with MG: penicillamine and cysteine have the highest reactivity
toward MG; aminoguanidine is about 10 fold less reactive than
penicillamine; metformin and glutathione do not exhibit any MG
scavenging ability. No signal is observed for TRI incubated with
scavengers alone, except with NAC. Hence, the reaction between
MG and TRI was chromatographically tested in various mixtures
with ﬂuorometric detection. The derivative products (6,7-
dimethylpterin) have ﬂuorescent properties that are not exhibited
by TRI or MG alone. The average retention time of TRI-MG
derivative is observed at 10.9 min. The signal is diminished in
the presence of dicarbonyl scavengers in the same way as results
obtained by TRI assay. Fig. 2 shows the chromatograms of
derivatized mixture samples prepared according to the TRI assay.
90% of the 6,7-dimethylpterin signal is reduced in the presence of
cysteine at 100 mM. NAC do not inhibit the signal of TRI-MG
adduct, even at higher concentration (5 mM). An additional
unidentiﬁed adduct is observed at 15.07 min. Its signal increases
with the time (up to 12 h) and reaches about 20% of the 6,
7-dimethylpterin signal after 1 h. This additional adduct observed
in HPLC experiments explains the high ﬂuorescent signal observed
with NAC in the TRI assay. Consequently, the production of
ﬂuorescent of unknown origin with NAC precludes its use in the
assay with TRI.
Therefore, we performed a screening assay for MG scavenger using
NBD-H reagent. Fig. 3a shows the absorbance and ﬂuorescence spectra
Table 2
Scavenging activity of MG and HNE in myeloma cells and screening assays.
Compounds Methylglyoxal 4-Hydroxynonenal
NBDHa TRIa Myeloma cellsb NBDHa CHDa Myeloma cellsb
RCS 0.1 mM 0.006 mM 1 mM 0.1 mM 0.1 mM 0.1 mM
L-cysteine 0.2370.03 0.02173103 600 0.1870.02 0.1170.01 0.6
Penicillamine 0.2670.03 0.0172103 700 0.8570.05 0.7570.05 0.88
Glutathione 2.570.03 40.6 2.1103 0.2470.03 0.2770.02 0.8
N-acetyl-cysteine 4.270.05 d 6.2103 0.4870.04 0.5670.07 0.64
Aminoguanidine 0.7470.16 0.1377103 103 870.6 0.4270.05 1.6
Cysteamine 0.2270.03 0.1770.02
Homocysteine 0.7970.17 0.1770.02
WR-1065 0.870.14 0.1270.02
Pyrodoxamine 410c 410c
Metformin 410c 41 45103 410c 410 45
Captopril 6.070.5 1.070.2
Carnosine 410c 410c
β-Alanine 410c 410c
a IC50 values expressed in mmol/l corresponding to 50% of inhibition of carbonyl derivative formation.
b IC50 values expressed in mmol/l corresponding to 50% of toxicity induced at 1 mM and 100 mM for MG and HNE respectively. Each data point is the mean7SD from
triplicate determinations. Each treatment is compared with control, and statistical signiﬁcance between two groups is evaluated using Student's t test.
c p40.05 versus control in the absence of scavenger.
d Fluorescence signal higher than control.
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Fig. 1. Derivatization of aldehydes with ﬂuorimetric agents. Derivatization of
dicarbonyl with TRI to form 6-methylpterin (A), derivatization of monoaldehyde
with CHD (B), derivatization of mono and dicarbonyl with NBD-H (C).
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of NBD-H incubated withMG. NBD-H andMGwere reacted for 10 min
at 37 1C in pH 7.4 phosphate buffer solution. As shown in Fig. 3a, the
absorption spectrum of NBD-MG shows a maximum at 500 nm and
the emission spectrum presents a maximum at 560 nm. The ﬂuores-
cence spectra of NBD-HNE are similar to those exhibited by the
NBD-MG derivative. The kinetic of the reaction of NBD-H (200 μmol/L)
with 100 μmol/L of MG and HNE was also examined at 37 1C and pH
7.4 (Fig. 3b). The time-course of the appearance of the ﬂuorescence
(ex.500 nm; em.560 nm) shows that after 6–8min of incubation there
is no more ﬂuorescence increase. After 6 min a plateau is reaches and
the ﬂuorescence intensity is stable for about 60 min. Fluorescence
intensity was also monitored when reacting of NBD-H reagent
(200 mM) with increasing amounts of HNE and MG (0.05–20mM)
(Fig. 3c). The ﬂuorescence increase observed after reaction of NBD-H
with increasing amounts of carbonyl compounds reaches saturation at
a molar ratio of carbonyl to NBD-H of approximatively 50:1. This effect
could be due to one or more additional adducts as observed by 1H
NMR. A complex 1H NMR spectrum was obtained and cannot be
unambiguously assigned as the NBD-MG adduct. For a concentration
of carbonyls higher than 20mM, almost no more ﬂuorescence
increase appears. A linear plot is observed up to a molar ratio
carbonyls/NBD-H of 5 (r2¼0.994 and r2¼0.993 for MG and HNE
respectively). The signal corresponding to the ratio 1:1 reaches about
10% of the maximum intensity observed for the ratio 50:1.
Fluorescence response of RCS decreases linearly with the amount
of added scavenger. In the case of methylglyoxal (100 mM), the
inhibition shows a linear dependance with the amount of penicilla-
mine up to 400 mM (Fig. 4a). The scavenging effect also depends on the
time of incubation of scavenger with the RCS. A non-linear decrease is
observed with incubation time. The signal is reduced by half for both
MG and HNE after 30 min (Fig. 4b).
Results from the NBD-H assay show that cysteine and penicil-
lamine have the best scavenging ability toward MG (Table 2).
Aminoguadinine is also good MG scavenger but is about 3 fold less
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effective than cysteine. Glutathione and NAC do not show strong
activity and are more than 11 and 27 fold less effective respectively
than cysteine. Interestingly, a good correlation between MG trap-
ping ability measured with the NBD-H and TRI assays is observed
(r¼0.943). In addition, the correlation coefﬁcient for IC50 values
between our cell-based assay and NBD-H assay presents a close
interrelation.
Table 2 also express the scavenging ability of reference com-
pounds toward HNE using NBD-H and CHD assays. Molar ratio
values for each test compounds are quite similar between the two
assays (r¼1). Penicillamine is poorly reactive toward HNE and is
about 5–7 fold less effective than cysteine which presented the
best HNE scavenger ability. Glutathione also exhibits a good
scavenging ability and aminoguanidine is a poor HNE scavenger.
Elsewhere, the comparability of the screening NBD-H assays and
cell culture experiments for reaction of both MG and HNE is
reasonably good (r¼0.952 and 0.943 respectively). Efﬁcacy of
other thiol- and non-thiol-carbonyl pharmacophores was then
evaluated for their scavenging capacity toward MG and HNE using
our NBD-H assay. Fig. 5 shows their chemical structures. Results
with carbonyl scavengers expressed in molar ratio scavenger/
carbonyl corresponding to 50% of reagent derivatives inhibition
are reported in Table 2. Cysteamine shows high and similar
efﬁciencies toward MG and HNE than cysteine. Homocysteine is
more effective toward HNE than MG. WR-1065 do not exhibit a
strong MG scavenging ability but is the best HNE scavenger,
inhibiting 50% of NBD-H adduct for a molar ratio WR-1065/HNE
of 1.2 (po0.05). Glutathione and NAC also have good scavenging
ability toward HNE and are more effective than penicillamine or
captopril, which are slightly reactive. The others compounds are
not reactive toward HNE. The three best MG scavengers are
cysteamine, cysteine and penicillamine (po0.05). The three best
HNE scavengers are WR-1065, cysteamine and homocysteine
(po0.05).
Inhibition of AGE formation
Potential inhibition of AGE formation by test compounds was
evaluated using MG-, HNE- and glucose-glycated BSA as molecular
models by monitoring changes in the intensity of the ﬂuorescence
(λex¼330–345 nm/λem¼392–396 nm) that is commonly used to
detect the formation of glycated products [33–35].
Without AGE inhibitors, glycation of BSA (50 mg/ml) with MG
(5 mM) or glucose (20 mM) results in rapid production of AGEs,
almost within 24 h under the experimental conditions used. The
increase in the relative intensity of the ﬂuorescence for glycated
BSA is faster with HNE and MG than with glucose during the ﬁrst
24 h (12 and 4 fold respectively). Hence, compared with HNE and
MG, glucose is less active in glycation of BSA. The inhibition effects of
various compounds on AGE-BSA formation expressed in equivalent
of aminoguanidine are reported in Fig. 6. Of the compounds
similarly tested, aminoguanidine is the most effective on the
inhibition of MG-glycated. 50% of inhibition is observed for a molar
ratio aminoguanidinine/MG of 0.65. Penicillamine, cysteamine and
cysteine present a similar activity with IC50 values slightly weaker
than aminoguanidine (po0.05). AGE formation by MG is markedly
less inhibited by other compounds except for carnosine and β-
alanine, which have no inhibitory effect (p40.05).
Cysteine and WR-1065 strongly affect AGE formation. 50% of
inhibition is observed for a molar ratio cysteine/HNE of 0.55. Effect
of cysteine on the inhibition of HNE-glycated is about 1.3 fold
higher than penicillamine and cysteamine, and 5 fold higher than
aminoguanidine, which show IC50 value of 13.8 mM (po0.05).
The other compounds only fairly inhibit AGE formation by HNE.
Carnosine and β-alanine have no inhibitory effect (p40.05). All
tested compounds affect BSA glycated by glucose.
Concerning AGE formation by glucose, aminoguanidine shows
the best inhibitory activity with IC50¼1.15 mM which is about
5 fold higher than carnosine the weaker inhibitor observed.
Discussion
Many of the carbonyls that are produced result from either lipid
peroxidation or glycoxidation are extremely reactive. Unsaturated
aldehydes are the most reactive. Reactive carbonyl species induce
the carbonyl stress characterized by the formation of adducts and
cross-links on proteins, which progressively leads to damages in
cells and tissues. Alkenals such as HNE, which are formed during
lipid peroxidation, contained a C2–C3 unsaturated bond in addi-
tion to the C1 aldehyde, which make the C3 carbon a strong
electrophilic center that can undergo Michael addition by nucleo-
philic groups on proteins, DNA, and lipids thereby causing damage
to these molecules. HNE is extremely reactive because of the
interaction between the electrophilic double bond, the aldehyde
moiety and the hydroxyl group [36]. Reducing sugars such as
glucose can form Schiff bases with amino groups on the amino
acids lysine and arginine, a reaction know as the Maillard reaction.
This can through a series of rearrangements, give rise to ﬂuor-
escent AGE [1,37]. Oxidation of these glycation products can
release dicarbonyls (G and MG), which can also react with
proteins, this greatly increases the rate of AGE formation and
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protein cross-link. Hence, the use of carbonyl scavengers by
inhibiting the formation of protein cross-links represents a ther-
apeutically strategy to prevent the RCS-induced damages and
carbonyl stress. Most of the carbonyl stress inhibitors used so far
have been evaluated in several model using analytical chemistry
techniques, which are labor intense, costly, time-consuming, or
with slow response time. These methods mainly based on AGE
detection [20,38–40], measurement of carbonyl-proteine/peptide
adducts [41] and cell viability [10,32], did not highlight a carbonyl-
quenching mechanism.
In this context, we have developed a rapid, simple and accurate
ﬂuorescent assay adapted to 96 wells microplate, to evaluate the
global carbonyl trapping ability in order to design novel agents
able to detoxify carbonyl compounds. In general, the ﬂuorescent
labelling reagents composed of a highly ﬂuorescent moiety and a
tagging moiety, which react with the functional group of analytes
to form the ﬂuorescent derivatives, are undesirable because of
interference from the ﬂuorescence of the reagents themselves.
We have overcome this disadvantage in our method by using
NBD-H which is non-ﬂuorescent themselves and react with both
mono and dicarbonyls to form highly ﬂuorescent derivatives, and
therefore have an advantage as they avoid interfering with the
ﬂuorescence of the reagent themselves. In addition, since their
excitation and ﬂuorescence wavelengths are at longer wavelengths,
detection of carbonyl derivatives has less interference by contami-
nants, and a highly sensitive detection can be done because of its
high reactivity.
To date, the scope of carbonyl-sequestering chemistries tested
is quite conventional, including compounds comprising nucleo-
philes directed against the carbonyl group (e.g., hydrazine, amine,
and bisulﬁte) as well as those targeting the double bond of
unsaturated carbonyl compounds (e.g., thiol-containing nucleo-
philes). It is noteworthy that thiol and amino group nucleophilicity
enhance carbonyl scavenger potency. Several RCS scavengers have
been proposed, including GSH, NAC, pyridoxamine, aminoguani-
dine and other nucleophilic compounds able to trap RCS inter-
mediates in AGE formation. The most extensively studied in vitro
and in vivo is aminoguanidine, which is a scavenging agent of α,
β-dicarbonyls being able to prevent the formation of AGEs from α,
β-dicarbonyl precursors [42,43]. Effective scavengers tested in our
screen are all characterized by at least one nucleophilic center,
such as thiol, imidazole, or primary amine group responsible for
the scavenging effect. The scavenging mechanism depends on the
target aldehyde and on the nucleophilic group of the scavengers.
In the case of MG scavenging, compounds bearing two nucleo-
philic centers are more efﬁcient due to the subsequent more
energy favourable 5- and 6-membered ring formation, as observed
in Table 2. It was previously observed that the reaction of MG with
cysteine or penicillamine under physiological conditions was
very fast and reversible, leading to the formation of heterocyclic
2-acetylthioazolidine and 2-acetylthiazole after rearrangement
and oxidation reactions [32,44,45]. A difference can be noticed
between cysteine and homocysteine due to the additional methy-
lene group in the last compound, leading to the formation of a less
favourable 7-membered ring. The same observation can be sug-
gested for glutathione, where cyclization is not expected to occur.
WR-1065 exhibited a moderate activity that could be due to the
steric hindrance around the secondary amine and its higher pKa
value. Aminoguanidine is mono-functional molecule and cannot
lead to the formation of an enthalpy-favoured cycle. However, due
to the presence in β-position of an additional heteroatom, this
compound behaves as highly reactive nucleophiles (β-effect). NAC
and captopril exhibit both the lowest reactivity with MG due to the
presence of a single nucleophilic sulfuryl group on the molecule.
Concerning HNE scavenging, the reaction scheme is different
from the one for MG, i.e. with a one-step process involved. Thus a
Michael adduct is formed by the addition of a nucleophilic sulfur
or nitrogen atom to the electrophilic carbon-3 of HNE [46]. The
most efﬁcient scavengers are the ones bearing the highest number
of nucleophilic groups. For instance, WR-1065 bearing three
nucleophilic groups exhibits a smaller IC50 value than cysteamine,
cysteine or homocysteine, with two reactive centers, following by
NAC and captopril with only one reactive sulfuryl group. Com-
pared to cysteine, the presence of a gem dimethyl group in beta-
position of the thiol of penicillamine dramatically reduces its
quenching ability. Though aminoguanidine bears four potentially
reactive nitrogen atoms, these centers are weak nucleophiles due
to the protonation of the guanidine group at physiological pH.
It was shown that the reactivity of the SH groups of the
investigated thiols with MG decreased in the order cysteine4GSH4
NAC [47]. Elsewhere, the scavenging activity of penicillamine toward
the dicarbonyl phenylglyoxal was more efﬁcacious than aminoguani-
dine under physiological conditions in vitro [32]. Our data (Table 2) are
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Fig. 6. Inhibition of AGE-BSA formation by various compounds. BSA (50 mg/ml)
was incubated at 37 1C for 24 h in 0.4 M phosphate buffer, pH 7.4 in the absence
and presence of various concentrations of the compounds with (A) 5 mM methyl-
glyoxal, (B) 5 mM 4-Hydroxynonenal, (C) 20 mM glucose. IC50 values of inhibition
of AGE-BSA formation are expressed in equivalent of aminoguanidine. Each data
point is the mean7SD from triplicate determinations. In addition, one-way ANOVA
of the values yielded po0.01. *p40.05 versus controls in the absence of scavenger.
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in agreement with these ﬁndings indicating the requirement of an
α-amino-β-mercaptoethane structure for the highest degree of inhibi-
tory activity. Interestingly penicillamine trapp phenylglyoxal more
effectively than the corresponding mono-aldehyde HNE, a ﬁnding
that may be explained by the expected higher electrophilicity of the
α-dicarbonyl compound. The α-dicarbonyl adduct is stable in water,
whereas the monocarbonyl-derived thiazolidine adducts form rever-
sibly with subsequent release of the aldehyde [48]. This could explain
the higher inhibition efﬁciency of penicillamine toward MG than HNE
observed in our screening assay. Cysteamine quenches in 50% MG
for a molar ratio cysteamine to MG of 2:1 according our NBD-H assay.
The pathophysiological concentration of MG in blood is in the range of
0.8–3 mM [49,50]. As the scavenging effect is dependant on the time
of incubation of scavenger with the RCS and considering other
RCS targets, it is difﬁcult to estimate the effective concentration of
cyteamine into physiological situations. However, at its therapeutic
concentration in plasma (440 mM at range 1–2 h) [51], cysteamine
could exhibit a protective effect against MG.
Millimolar concentrations of inhibitory test compounds are
required to observe inhibition of the strong glycation activity of
MG, HNE and glucose at the millimolar test concentration chosen
to create a rapid glycation reaction. Although aminoguanidine
shows an unfavourable toxicity proﬁle in vivo, it was chosen as
a reference inhibitor of glycation by α-dicarbonyl scavenging [43,52].
We observed that nucleophilic monoamines such as carnosine and
beta-alanine do not suppress formation of AGE ﬂuorescence by
MG and HNE in our screening system, most probably undergoing
preferential glycation themselves. In this study, we have focused
our screening efforts on thiol compounds as another class of
nucleophilic agents expected to interfere with glycation. The
inhibitory effects of penicillamine as observed in the reaction
between MG or HNE and BSA may be linked mechanistically to its
very strong reactivity towards both mono and dicarbonyls.
Cysteine and the decarboxylated derivative cysteamine show also
improved inhibitory activity, whereas homocysteine was less
effective. The results obtained are in agreement with earlier
studies showing that NAC, cysteine and GSH lowered AGE ﬂuor-
escence [29,53].
In our cell experiments extracellularly applied, MG and HNE are
shown to be toxic to mouse myeloma cells in a dose-dependent
manner above concentrations of 150 mM and 2 mM respectively.
Although concentrations of MG and HNE used in our cell models
were much higher than the physiological ones (0.5–1 μM and
0.1–0.2 mM for MG and HNE respectively in plasma from healthy
subjects [54,55]), our ﬁndings allow for extrapolation of the results
to conditions close physiological. The tested carbonyl scavengers
are well tolerated and clearly protected myeloma cells against the
toxic action of methylglyoxal and HNE.
The scavenging effects of cysteine and penicillamine in cells
experiments are more pronounced (ratio scavenger/RCSo1) than
in NBD-H assay. As the scavenging effect depend on the kinetic of
the reaction between scavenger and RCS, results of the assays can
differ widely based on the time of incubation of scavenger with
the RCS (30 min in the NBDH assay and 24 h in cells experiments).
As glutathione, cysteine and penicillamine are hydrophilic
compounds with log p value of 4.88, 2.79 and 2.15 respec-
tively; reactions probably occur in cell experiments in the extra
cellular environment and explain the protective effect of thiols
against MG and HNE toxicity. Cysteine has been also reported to
protect against acetaldehyde toxicity in vivo by its carbonyl
scavenging activity [56], but its catabolism limits its usefulness
in vivo. The activity of aminoguanidine toward α,β-dicarbonyls is
in part due to the strong nucleophilic amino group that forms a
stable Schiff base with the aldehyde function. However, in vivo this
mechanism strongly limits the speciﬁcity of aminoguanidine, since
it is not only active towards cytotoxic aldehydes, but also towards
biogenic and physiological aldehydic compounds such as pyridoxal
phosphate and pyruvate [57]. Moreover, aminoguanidine is a poor
scavenging agent of α,β-unsaturated aldehydes and do not prevent
HNE toxicity as demonstrated in our study. α,β-dicarbonyls and α,
β-unsaturated aldehydes are key reactive intermediates of cellular
carbonyl stress and therefore are both important targets for
therapeutic intervention in pathological conditions.
Much attention needs to be dedicated to elucidating the complex
kinetics and mechanism of the reaction of cysteine, penicillamine,
aminoguanidine and derivatives with several α-dicarbonyls and
unsaturated aldehydes. In our simpliﬁed approach, these carbonyls
are most probably detoxiﬁed by direct chemical trapping, establish-
ing the usefulness of carbonyl scavengers for protection of cells
against carbonyl stress. The screening method presented here will
allow identiﬁcation and further optimization of both mono- and
di-carbonyl scavenger pharmacophores. A good correlation is
observed between our screening methods and cell experiments for
all RCS tested. For MG, NBD-H and TRI assay give similar correlation
with cell experiments (r¼0.952 and r¼0.947 respectively). For HNE,
NBD-H shows also similar correlation than CHD with cell experi-
ments (r¼0.970 and r¼0.973 respectively) showing cysteine as the
best quencher of both MG and HNE. Although the structures of the
NBDH adducts have not been clearly established, the method
described is simple, sensitive and reproducible and could be used
for preliminary screening of candidate scavengers of RCS.
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